CervoMed CRVO
NASDAQ CRVO
$2.93 -0.04 (-1.35%)
At close: Oct 1, 2026 · 4:00 PM EDT

CervoMed (CRVO) EBITDA Margin (2011 - 2013)

Updated

CervoMed's EBITDA Margin was -11287.77% in Q2 2013, down 8904.25 percentage points from -2383.52% a year earlier.

Analysis

CervoMed (CRVO) EBITDA Margin (2011 - 2013) Analysis & Trends

For FY2012, EBITDA Margin at CervoMed came in at -3141.20%, down 282.26 percentage points from FY2011.

  • In earlier years, EBITDA Margin was -2858.94% in FY2011 (+16020.07 pp) and -18879.01% in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 35.95%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 49.01%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.02%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 33.11%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 46.01%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -124.26%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 39.10%
10 CervoMed 30.43 Mn 30.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 -11,287.77%
Sep 30, 2012 -2,383.52%
Jun 30, 2012 -2,383.52%
Mar 31, 2012 -1,468.13%
Dec 31, 2011 -2,649.82%
Sep 30, 2011 -1,646.06%
API Access

CervoMed EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEY